The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lacroix-Desmazes, S.
Right arrow Articles by Kazatchkine, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lacroix-Desmazes, S.
Right arrow Articles by Kazatchkine, M. D.
The Journal of Immunology, 1999, 162: 5601-5608.
Copyright © 1999 by The American Association of Immunologists

Defective Self-Reactive Antibody Repertoire of Serum IgM in Patients with Hyper-IgM Syndrome1

Sébastien Lacroix-Desmazes*, Igor Resnick{dagger}, Dorothea Stahl*, Luc Mouthon*, Teresa Espanol{ddagger}, Jacov Levy§, Srini V. Kaveri*, Luigi Notarangelo, Martha Eibl||, Alain Fischer#, Hans Ochs** and Michel D. Kazatchkine2,*

* Institut National de la Santé et de la Recherche Médicale (INSERM), Unit 430 and Université Pierre et Marie Curie, Hôpital Broussais, Paris, France; {dagger} Research Institute of Hematology, Moscow, Russia; {ddagger} Immunology Unit, Vall d’Hebron, Barcelona, Spain; § Department of Pediatrics, Soroka Medical Center, Beer Sheva, Israel; Department of Pediatrics, University of Brescia, Brescia, Italy; || Institute of Immunology, University of Vienna, Vienna, Austria; # INSERM, Unit 429, Hôpital des Enfants-Malades, Paris, France; and ** Department of Pediatrics, University of Washington Medical School, Seattle, WA 98195


    Abstract
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
We have analyzed the self-reactive repertoires of IgM and IgG Abs in the serum of 19 patients with hyper-IgM syndrome (HIM) by means of a quantitative immunoblotting technique that allows for a quantitative comparison of Ab repertoires in health and disease by multiparametric statistical analysis. Normal tissue extracts of liver, lung, stomach, and kidney were used as sources of self Ags. Extracts of Pseudomonas aeruginosa and Staphylococcus epidermidis were used as sources of nonself Ags. We demonstrate a significant bias in repertoires of reactivities of IgM of patients with HIM with self Ags. Ab repertoires of IgM toward nonself Ags did not differ, however, between patients and controls. No difference was found between IgM repertoires of untreated patients and those of patients receiving substitutive treatment with i.v. IgG. IgG in the serum of HIM patients lacked reactivity with self Ags, although it exhibited a pattern of reactivity with nonself Ags that was similar to that of IgG of healthy controls. The data demonstrate that functional CD40-CD40 ligand interactions are essential for the selection of natural self-reactive B cell repertoires.


    Introduction
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
Immunodeficiency with hyper-IgM syndrome (HIM)3 is a rare disease characterized by normal or increased serum concentrations of IgM with decreased or absent IgG, IgA, and IgE (1, 2). HIM results from defective interactions between CD40 ligand (CD40L) on activated T cells and CD40 on B cells. The X-linked form of HIM (X-HIM) is characterized by defective CD40L due to deletions/insertions, point mutations, or truncation in the CD40L-encoding gene (3, 4, 5, 6, 7, 8, 9, 10, 11, 12). Several in vivo and in vitro studies have documented that T cell-dependent isotype switch is strictly dependent on cognate interactions involving CD40 and CD40L and that impaired CD40-CD40L interactions inhibit the development of germinal centers and the generation of B memory cells (13, 14, 15, 16, 17). Patients with HIM lack germinal centers in secondary lymphoid organs (18). The patients suffer from recurrent upper and lower respiratory tract infections and also present with an unusual susceptibility to Pneumocystis carinii pneumonia and Cryptosporidium infection, suggesting impaired T cell functions. HIM patients often present with persistent neutropenia and may develop thrombocytopenia or other autoimmune manifestations such as hemolytic anemia and nephritis (1, 19). An increased incidence of autoantibodies, including anti-erythrocyte, anti-platelet, anti-thyroid, anti-nuclear, anti-cardiolipin, and anti-smooth muscle Abs, has been reported in patients with HIM (19, 20, 21, 22, 23).

Natural Abs of the IgM, IgG, and IgA isotypes that are reactive with a broad range of self Ags are present in normal serum (24, 25, 26). Ab repertoires of natural IgM and IgG toward self Ags are highly homogeneous among healthy individuals and remain invariant with aging (27, 28, 29, 30). Evidence obtained in mice suggests that the selection of autoreactive B cells requires the presence of CD4+ T lymphocytes under conditions of both pathological and physiological autoimmunity (31, 32, 33, 34).

In the present study, we analyzed the Ab repertoires of IgM and IgG in the serum of patients with HIM by means of a quantitative immunoblotting technique that allows for multiparametric statistical analysis of Ab reactivities with self and nonself Ags. We demonstrate that Ab repertoires of IgM toward self Ags are skewed in patients with HIM, whereas repertoires directed toward bacterial Ags do not differ between patients and healthy controls. In addition, little reactivity with self Ags of IgG in the serum of patients with HIM was detected. Our observations demonstrate that the lack of functional CD40-CD40L interactions and/or impaired T/B cell cooperation in HIM affect the selection processes of natural self-reactive B cell repertoires.


    Patients and Methods
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
Patients

EDTA-plasma was obtained from 19 children (18 boys and 1 girl), between 3 and 14 years old, diagnosed with immunodeficiency with HIM. Twenty healthy young adult male blood donors with a mean age of 34 ± 5 years were used as normal controls. Previous studies from our laboratory had demonstrated that self-reactive Ab repertoires in serum remain highly homogeneous and invariant from early childhood to adulthood (29, 35).

Sixteen of the male patients had X-HIM. Two male patients presented with autosomal recessive HIM, and one female patient had secondary HIM associated with congenital rubella. Activated PBMC totally lacked expression of the CD40L Ag in 11 X-HIM patients, whereas expression of the Ag was low in 3 patients (2 patients with X-HIM and 1 patient with autosomal recessive HIM) and unknown in the remaining 5 cases. All patients had suffered from severe and/or recurrent infections before diagnosis, including upper respiratory tract infections (10 of 16), P. carinii pneumonia (2 of 16), and episodic or chronic infectious diarrhea (6 of 16 including Cryptosporidium infection in 3 cases). Hematological abnormalities included neutropenia in 11 patients and pure RBC aplasia in 2 patients due to parvovirus B19 infection, as previously reported (36). Nephritis was present in 1 patient and arthritis in 2 patients (described in 1). Autosomal recessive HIM was diagnosed in 2 patients with low or normal expression of the CD40L Ag, respectively, and suffering from upper respiratory tract infections. One patient had secondary HIM associated with congenital rubella. CD40L expression in this patient was normal, and the patient suffered upper respiratory tract infections. Twelve of the 19 patients received substitutive therapy with i.v. Ig, in amounts ranging from 200 mg/kg/body weight every 5 wk to 600 mg/kg every 2 wk. Seven of the 19 patients had not been treated with i.v. Ig at the time of serum sampling.

The mean serum IgM concentration in HIM patients was 3.8 ± 3.5 mg/ml (mean ± SD, ranging from 0.4 to 14) at the time of diagnosis, as determined by nephelometry. At the time of sampling, the mean IgM and IgG concentrations were 2.2 ± 2.2 and 0.7 ± 0.4 mg/ml, respectively, in the serum of the 7 patients who were not substituted with i.v. Ig. These concentrations were 2.3 ± 2.1 and 2.6 ± 2.1, respectively, in the serum of the 12 i.v. Ig-treated patients. The concentrations of serum IgM and IgG in healthy controls were 1.4 ± 0.5 and 11.8 ± 3.1 mg/ml, respectively. Sandoglobulin (a gift of the Central Laboratory of the Swiss Red Cross, Bern, Switzerland) was used as a standard for normal IgG. A reference preparation of normal IgM (i.v. IgM) was obtained by submitting Pentaglobin (Biotest Pharma, Dreieich, Germany), an IgM-enriched therapeutic preparation of pooled normal human IgG, to size exclusion chromatography on Sephacryl HR S-300 (Pharmacia, Uppsala, Sweden).

Analysis of Ab repertoires by quantitative immunoblotting

For the study of Ab repertoires, we have used a quantitative immunoblotting technique that allows the simultaneous assessment of reactivities of different sources of Abs with a large number of Ags in total tissue extracts (28, 37). The method has been described in detail elsewhere (27, 28). Extracts of histologically normal human kidney, lung, liver, and stomach were used as sources of self Ags. Sources of bacterial Ags were extracts of the commensal and pathogenic bacteria P. aeruginosa (Collection de l’Institut Pasteur, CIP A22) and Staphylococcus epidermidis (CIP 8155). Proteins were extracted from tissues and bacteria in 2.0% SDS, 1.45 M 2-ME, 125 mM Tris-HCl (pH 6.8), containing 1.0 µg/ml aprotinin, 1.0 µg/ml pepstatin, and 1.0 mM EDTA on ice. Samples were sonicated 4 times for 30 s to disrupt DNA and boiled for 5 min. Protein concentrations were determined by means of a Folin assay. The amount of tissue proteins subjected to electrophoresis and transfer ranged between 100 and 600 µg/gel, depending on the tissue extract, and was maintained constant for a given tissue in all experiments. Low amounts of carbohydrates could be detected in solubilized protein samples. Proteins were subjected to preparative SDS-PAGE in 10% polyacrylamide and transferred onto nitrocellulose (Schleicher & Schuell, Dassel, Germany) for 60 min at 0.8 mA/cm2 using a SemiDry Electroblotter A (Ancos, Denmark). Membranes were blocked with PBS-Tween. The source of Abs to be tested was then incubated with the membranes following the addition of one sample per slot in a Cassette Miniblot System (Immunetics, Cambridge, MA) overnight at 4°C. The membranes were washed and incubated with µ-chain-specific secondary goat anti-human IgM Ab (Southern Biotechnology Associates, Birmingham, AL) or secondary goat anti-human Fc{gamma} Ab coupled to alkaline phosphatase (Sigma, St. Louis, MO). Immunoreactivities were revealed using the nitroblue tetrazolium/bromochloroindolyl phosphate substrate (Promega, Madison, WI). The dependency on variable regions of the recognition of blotted Ags by IgM and IgG has been documented previously (27, 28). Quantitation of immunoreactivities was performed by densitometry in reflective mode using a high resolution CCD camera system (Masterscan, Scanalytics, Billerica, MA). Blotted proteins were then stained using colloidal gold (Protogold) (Biocell, Cardiff, U.K.) and subjected to a second densitometric analysis to score the protein profile and to quantitate transferred proteins. Data were analyzed using a Quadra 650 computer (Apple Computer, Cupertino, CA) and IGOR software (Wavemetrics, Lake Oswego, OR). Densitometric profiles of immunoreactivity were compared by referring to their corresponding protein profile, following correction of the migration defects by superimposition of protein peaks. A sample of the reference IgM or IgG preparations was included in each blot, to rescale the different membranes transferred with a given protein extract and to adjust for the intensity of staining of different membranes.

Analysis of the densitometric profiles obtained with serial dilutions of i.v. Ig demonstrated a dose-dependent decrease in the area under the curve corresponding to peaks of reactivity for concentrations of IgG between 50 and 400 µg/ml and of IgM between 5 and 50 µg/ml. Saturation was achieved for concentrations of IgG and IgM above 400 and 50 µg/ml, respectively. The reproducibility of the assay was 10% (variation coefficient). The 95% confidence interval of the mean area under the curve corresponding to each peak of immunoreactivity was 30% in the case of IgM and 25% in the case of IgG, as calculated by Student’s t test (27, 28).

Statistical analysis

Densitometric profiles of immunoblots were divided into sections corresponding to individual peaks of immunoreactivity. Respective peak areas were calculated in the case of each tissue extract. To discriminate between individual repertoires, peak areas corresponding to sections obtained with all self Ags were submitted simultaneously to principal component analysis (PCA) (38), using Mathematica (Wolfram Research, Champaign, IL) software. The repertoire of reactivities of each individual in a given sample was represented as a single symbol in a two-dimensional linear subspace. Discrimination between repertoires was assessed by submitting PCA data to linear discriminant analysis (LDA) and by subsequently comparing factors 1 of the LDA by Mann-Whitney U test. The statistical comparison required that factor 1 of the LDA accounted for >70% of the variance of the data. PCA of repertoires of Ab reactivities performed individually for each group of individuals further allowed the calculation of respective variances. Variances were compared by F test. We also quantitated total immunoreactivities of serum IgM with each source of Ags by computing the total area under the curves of the respective densitometric profiles. Mean values of total reactivities obtained with each source of Ag were compared between groups of individuals in a global analysis by Fisher’s test.

Analysis of IgM reactivity by ELISA

Ninety-six-well ELISA plates (Nunc, Roskilde, Denmark) were coated with human Ag H (a gift from Prof. J.-P. Cartron, Institut National de la Santé et de la Recherche Médicale (INSERM), Unit 76, Paris, France), human laminin (Sigma), human thyroglobulin (Biogenesis, Poole, U.K.), human transferrin (Sigma), calf actin, and calf thymus DNA (Sigma) at 10 µg/ml in PBS, pH 7.4, and with human low density lipoprotein (LDL, a gift from J. Chevalier, INSERM, Unit 430, Paris, France) at 10 µg/ml in PBS, 2.7 mM EDTA, and 20 µM butylated hydroxytoluene (Sigma) overnight at 4°C. Plates coated with DNA had been pretreated with 10 µg/ml poly-L-lysine (Sigma). Plates were saturated with 1.0% BSA (Sigma) in PBS for 30 min at 37°C. After a washing with PBS, the plates were incubated with decreasing concentrations of serum IgM to be tested for 1 h at 37°C before extensive washing with PBS and addition of goat anti-human IgM Abs coupled to alkaline phosphatase (Southern Biotechnology Associates). The background reactivity of serum IgM scored with nonsensitized plates, or with poly-L-lysine-treated plates in the case of DNA, was subtracted from the reactivity of IgM with the respective Ags. The mean values of the corrected IgM reactivities were compared between groups for each Ag by means of an one-sided Student t test.


    Results
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
Reactivity with self Ags of serum IgM of patients with the hyper-IgM syndrome

The reactivity with self Ags of IgM in the serum of healthy blood donors and patients with HIM was analyzed by immunoblotting using extracts of normal homologous human kidney, lung, liver, and stomach as sources of self Ags. From 20 to 30 major peaks of reactivity were scored after blotting of IgM of healthy individuals with Ags in the extracts (Fig. 1Go and data not shown). As previously reported (28, 35), the densitometric profiles of reactivity of IgM of healthy donors exhibited a strong homogeneity between individuals with regard to the nature of the protein bands recognized in all tissue extracts that were tested. From 15 to 20 major peaks of reactivity were also detected after blotting of IgM of patients with HIM with self Ags (Fig. 1Go and data not shown). The densitometric profiles of IgM reactivities exhibited a strong homogeneity between patients with regard to the nature of the protein bands recognized and were also homogeneous with regard to the intensity of immunoreactivities in lung and stomach Ags, but not in kidney and liver Ags (Fig. 1Go and data not shown).



View larger version (38K):
[in this window]
[in a new window]
 
FIGURE 1. Densitometric profiles of the reactivity of serum IgM of 20 healthy donors (A and C) and of 19 patients with hyper-IgM syndrome (B and D) with Ags in extracts of normal human stomach (A and B) and liver (C and D). Sera were diluted to an IgM concentration of 20 µg/ml. The densitometric pattern of reactivity of IgM of each individual is depicted as a full line curve. Gray areas depict the densitometric pattern observed in the presence of the secondary anti-Fcµ Ab alone. Migration distances and optical densities are expressed as arbitrary units (A. U.).

 
To compare the densitometric profiles of reactivities of IgM of healthy donors and patients, we computed the arithmetic mean reactivity profiles with self Ags of IgM of the 20 healthy donors and 19 patients (Fig. 2Go). Most of the protein bands detected by IgM in the serum of healthy donors were also recognized by HIM IgM with lower intensity. Several of the IgM reactivities expressed by healthy subjects were not present in the repertoire of reactivities of IgM of HIM patients. The overall reactivity with self Ags of IgM of the HIM patients, as calculated by computing the mean area under the curve of the densitometric profiles obtained with each tissue extract, was significantly lower than that of healthy individuals in kidney, liver, and stomach Ags, but not in lung Ags (Table IGo).



View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 2. Comparative analysis of self-reactive IgM Abs in the serum of healthy donors and of patients with hyper-IgM syndrome. Depicted are the mean densitometric profiles of self-reactive IgM (i.e., the arithmetic mean of the 800 recorded intensities constitutive of the reactivity profile of each individual) in the serum of 20 healthy donors (black areas and dotted lines) and of 19 patients with HIM (white areas), with Ags in extracts of normal human liver (A) and stomach (B). IgM was tested at a concentration of 20 µg/ml. Gray areas depict the densitometric pattern observed in the presence of the secondary anti-Fcµ Ab alone. Migration distances and optical densities are expressed as arbitrary units (A. U.). Insets depict the results of PCA of the repertoires of reactivities of IgM in the serum of healthy donors (•) and patients ({square}). For each donor, the densitometric profile of reactivity with a given tissue extract was divided into sections corresponding to peaks of reactivity so as to calculate the height of each peak. The data were subjected to PCA within a 31- to 56-dimension vector space, depending on the tissue extract, and fitted within two-dimensional linear subspaces (factors 1 and 2). Percentages of variance accounted for by factors 1 and 2 are indicated on the abscissa and ordinate, respectively. Each symbol represents the reactivity of IgM of a single individual. In both liver and stomach extracts, PCA discriminated between repertoires of patients and controls (p < 0.001 by the Mann-Whitney test).

 

View this table:
[in this window]
[in a new window]
 
Table I. Total reactivity with self-Ags of IgM in the serum of healthy individuals and patients with hyper-IgM syndrome1

 
To further compare the self-reactive repertoires of IgM of patients and healthy controls, we calculated the area of the peaks of immunoreactivity in densitometric profiles of IgM of each individual in each tissue extract. The data obtained with IgM of healthy donors were compared with those obtained in patients by PCA within a 31- to 56-dimension vector space, depending on the tissue extract, and fitted into the two-dimensional linear subspace that accounted for 55.6 to 69.4% of the variance and allowed the most powerful discrimination of the individuals (Fig. 2Go). The data obtained by PCA were then submitted to LDA. Factors 1 of LDA were then compared by means of the Mann-Whitney U test. PCA discriminated between repertoires of Ab reactivities with self Ags of healthy donors and patients with HIM (p < 0.001 in the case of all tissue extracts). PCA did not discriminate between self-reactive repertoires of HIM patients undergoing substitutive therapy with i.v. Ig and untreated patients (data not shown), indicating that the administration of normal IgG to HIM patients does not restore a physiological pattern of self-reactivity of IgM. PCA did not discriminate between self-reactive IgM Ab repertoires of patients with X-HIM and the patients with autosomal recessive HIM (data not shown). We then assessed the relative homogeneity of Ab repertoires of the 19 patients and 20 controls, by calculating the individual variances of the repertoires of self-reactivities in the case of each protein extract, by means of PCA. The variances did not differ significantly between healthy donors and HIM patients (Table IIGo), demonstrating that self-reactive repertoires of IgM were homogeneous in both groups of individuals. Taken together, these data document that self-reactive repertoires of IgM of patients with HIM differ significantly from those of healthy donors.


View this table:
[in this window]
[in a new window]
 
Table II. Total variances of the self-reactive repertoires of IgM of healthy individuals and of patients with hyper-IgM syndrome1

 
We then analyzed the reactivity of IgM in the serum of healthy blood donors and patients with HIM in the case of several individual self Ags by ELISA. The reactivity of serum IgM of HIM patients with DNA and with protein autoantigens, i.e., actin, laminin, thyroglobulin, and transferrin, was significantly lower than that of healthy blood donors (Fig. 3Go). The reactivity of IgM from patients with HIM was, however, identical with that of healthy subjects in the case of Ag H and LDL (Fig. 3Go), suggesting that the nature of the autoantigen determines whether T cell help is required for the selection of autoreactive B cell clones.



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 3. Reactivity of serum IgM of 12 healthy donors ({blacksquare}) and of 12 patients with HIM ({square}) with a panel of self Ags, i.e., actin (Act), laminin (Lam), thyroglobulin (Tg), transferrin (Tf), DNA, Ag H, and LDL. Mean reactivities of IgM, at a concentration of 33 µg/ml as assessed by ELISA, are expressed as arbitrary units (A. U.). Mean IgM reactivities were compared between groups using an one-sided Student t test (*, p < 0.05; {dagger}, p < 0.01).

 
Reactivity with nonself Ags of serum IgM of patients with the hyper-IgM syndrome

To investigate Ab repertoires against nonself Ags, we assessed the reactivity of IgM of patients with HIM with extracts of P. aeruginosa and S. epidermidis. The densitometric profiles of reactivity of IgM of healthy donors and HIM patients exhibited between 10 and 20 and between 5 and 10 major peaks of reactivity with the 2 sources of bacterial Ags, respectively (data not shown). The densitometric profiles of IgM of healthy donors exhibited a strong homogeneity between individuals with regard to the nature of the protein bands recognized and the intensity of the peaks, whereas densitometric profiles of IgM of patients were homogeneous in the case of P. aeruginosa extracts and heterogeneous in that of extracts of S. epidermidis (data not shown). The total reactivity of IgM of HIM patients with the bacterial extracts did not differ significantly from that of healthy individuals (Table IIIGo). We then computed the areas of the peaks of immunoreactivity in the densitometric profiles to allow for multiparametric analysis of the data. The data obtained in healthy donors and patients were compared by means of PCA within a 46- to 58-dimension vector space, depending on the bacterial extract, and fitted into the 2-dimensional linear subspace that accounted for 69.5 to 70.3% of the variance and allowed for the most powerful discrimination between individuals. PCA did not discriminate between repertoires of reactivities with bacterial Ags of patients and healthy donors (Fig. 4Go). PCA also did not discriminate between autoantibody repertoires of patients with X-HIM and patients with autosomal recessive HIM (data not shown). When calculating the individual variances of repertoires of reactivity of IgM with bacterial Ags by PCA (Table IVGo), variances of repertoires of healthy donors were found not to differ significantly from those of repertoires of HIM patients, indicating that the relative homogeneity of the repertoires of reactivities of IgM to external Ags was similar in the two groups of individuals. Thus, patients with HIM appeared to generate an IgM Ab repertoire to commensal bacteria similar to that of healthy individuals, contrasting with impaired Ab repertoires to self Ags.


View this table:
[in this window]
[in a new window]
 
Table III. Total reactivity with foreign Ags of IgM in the serum of healthy individuals and patients with hyper-IgM syndrome1

 


View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 4. Comparative analysis of reactivity of IgM Abs in the serum of 20 healthy donors (•) and of 20 patients with hyper-IgM syndrome with foreign Ags ({square}). Depicted are the results of PCA of the repertoires of reactivities of IgM with Ags in extracts of P. aeruginosa (top) and S. epidermidis (bottom). For each donor, the densitometric profile of reactivity with a given tissue extract was divided into sections corresponding to peaks of reactivity so as to calculate the height of each peak. The data were subjected to PCA within a 46- to 58-dimension vector space, depending on the bacterial extract, and fitted within two-dimensional linear subspaces (factors 1 and 2). Percentages of variance accounted for by factors 1 and 2 are indicated on the abscissa and the ordinate, respectively. Each symbol represents the reactivity of Igs of a single individual. In both P. aeruginosa and S. epidermidis extracts, PCA did not discriminate between repertoires of patients and controls.

 

View this table:
[in this window]
[in a new window]
 
Table IV. Total variances of the repertoires of reactivity of IgM of healthy subjects and of patients with hyper-IgM syndrome with Ags in bacterial extracts1

 
Reactivity with self and nonself Ags of IgG in serum of patients with the hyper-IgM syndrome

We analyzed the repertoires of reactivity of IgG in the serum of 7 patients who had not been substituted with i.v. Ig and of 5 control healthy subjects. The concentration of IgG in patients’ serum was <0.4 mg/ml in 3 patients and ranged between 0.6 and 1.2 mg/ml in the 4 remaining patients. Reactivities of IgG were tested in serum diluted to achieve a final IgG concentration of 200 µg/ml. IgG of healthy donors strongly reacted with 20–30 protein bands, depending on the tissue extract (data not shown). As previously described (27), the patterns of reactivities were heterogeneous among healthy individuals with regard to both the nature of the protein bands recognized and the intensity of reactivities. No reactivity with self Ags and nonself Ags was seen with serum of the 3 patients who exhibited the lowest concentrations of serum IgG. IgG of the remaining 4 HIM patients exhibited weak reactivity with 10 to 15 protein bands in the kidney extract (data not shown). In contrast, a strong reactivity was observed with Ags in the S. epidermidis extract (data not shown). The total reactivity of IgG of HIM patients was significantly lower than that of healthy blood donors in the case of kidney Ags (p < 0.001), but not in that of S. epidermidis Ags (p = 0.66) (Fig. 5Go and Table VGo), indicating a selective bias in the repertoire of reactivities of IgG toward self Ags.



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 5. Comparative analysis of repertoires of IgG Abs in the serum of healthy donors and patients with HIM. Depicted are the mean densitometric profiles of IgG in the serum of 7 healthy donors (black areas and dotted lines) and 4 patients with HIM who had not received i.v. Ig (white areas), with Ags in extracts of normal human kidney (top) and S. epidermidis (bottom). IgG was tested at a concentration of 200 µg/ml. Gray areas depict the densitometric pattern observed in the presence of the secondary anti-Fc{gamma} Ab alone. Migration distances and optical densities are expressed as arbitrary units (A. U.). Insets depict the results of PCA of the repertoires of reactivities of IgG in the serum of healthy donors (•) and patients ({square}). For each donor, the densitometric profile of reactivity with a given tissue extract was divided into sections corresponding to peaks of reactivity so as to calculate the height of each peak. The data were subjected to PCA within a 42- to 44-dimension vector space, depending on the tissue extract, and fitted within 2-dimensional linear subspaces (factors 1 and 2). Percentages of variance accounted for by factors 1 and 2 are indicated on the abscissa and ordinate, respectively. Each symbol represents the reactivity of IgG of a single individual. PCA discriminated between repertoires of patients and controls in kidney extract (p < 0.01 by the Mann-Whitney test), whereas it did not discriminate between patients and controls in S. epidermidis.

 

View this table:
[in this window]
[in a new window]
 
Table V. Total reactivity of IgG in the serum of healthy individuals and patients with hyper-IgM syndrome1

 
The data obtained upon immunoblotting of IgG were compared by means of PCA within 44- and 42-dimension vector spaces, in the case of kidney and S. epidermidis extracts, respectively, and fitted into 2-dimensional linear subspaces that accounted for 91.4 and 70.0% of the variance, respectively. PCA discriminated between healthy donors and patients in the case of kidney Ags (p < 0.05), whereas it did not discriminate between repertoires of reactivity with S. epidermidis of healthy individuals and HIM patients (p = 0.22) (Fig. 5Go). Individual variances of the repertoires of reactivity of IgG with both kidney and S. epidermidis Ags, calculated by PCA, differed significantly between healthy donors and patients (Table VIGo), indicating a higher degree of heterogeneity of the repertoires of reactivity of IgG in healthy subjects than in HIM patients.


View this table:
[in this window]
[in a new window]
 
Table VI. Total variances of the repertoires of reactivity of IgG of healthy subjects and of patients with hyper-IgM syndrome1

 

    Discussion
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
In the present study, we have characterized the Ab repertoires of IgM and IgG in the serum of patients with the hyper-IgM syndrome. We demonstrate a significant bias in repertoires of reactivities of IgM of patients with HIM with self Ags. Furthermore, IgG of HIM patients lacked reactivity with self Ags, in contrast with IgG of healthy controls, when tested at similar concentrations. Repertoires of reactivities of HIM IgM with foreign Ags did not differ from those of IgM in the serum of healthy individuals. These results indicate that the lack of functional CD40-CD40L interactions or defective T cell/B cell cooperation impact on the selection of physiological self-reactive Ab repertoires.

Natural autoreactive IgM and IgG Abs are found in the serum of healthy individuals (24, 39). The normal repertoire of Ab reactivities with self Ags is homogeneous between individuals and restricted to a limited set of immunodominant Ags that is conserved among healthy individuals and stable throughout life (27, 28, 29, 35). Repertoires of serum IgM and IgG remain invariant in children and young adults and between males and females with regard to reactivity with self Ags (29, 35, 40). Significant alterations in self-reactive Ab repertoires have been observed in autoimmune conditions, such as myasthenia gravis and systemic lupus erythematosus (41, 42).

Here we investigated Ab repertoires in the serum of 19 patients with HIM, 16 of whom had X-HIM. We observed that the densitometric patterns of reactivity with self Ags of IgM in the serum of patients with HIM were homogeneous among the patients but differed significantly from those of healthy donors. Several peaks of self-reactivity of IgM in normal serum were lacking in the serum of HIM patients. Principal component analysis discriminated between self-reactive IgM repertoires of patients and healthy donors. The variances of individual Ab repertoires were of a similar order of magnitude in both groups, indicating that healthy donors and patients with HIM represent homogenous groups of individuals characterized by distinct patterns of recognition of self Ags. These observations emphasize the key role of T lymphocytes for establishing natural self-reactive repertoires of IgM Abs, as suggested by previous studies in mice. Thus, it has been shown that euthymic and athymic (nu/nu) BALB/c mice present with distinct self-reactive repertoires of IgM (34). The transfer of syngeneic T cells to athymic mice restored high frequencies of autoreactive precursor B cell clones (33) and altered repertoires of reactivities of natural autoantibodies, with patterns almost identical with those of euthymic mice (34). The transfer of syngeneic T cells to nude mice was also shown to restore normal titers of serum IgG (33, 34).

A number of studies document a role for IgG in the selection of IgM repertoires. Thus, maternal IgG decreases the concentration and alters the pattern of reactivity of serum IgM in newborn mice (34, 43). Treatment with i.v. IgG of autoimmune patients, is followed by altered titers of specific IgM and IgG autoantibodies (44, 45, 46). In patients with HIM, the administration of i.v. Ig often results in a dramatic and long-lasting decrease of serum IgM levels (21, 23, 47, 48, 49). The latter decrease may reflect the effects of i.v. Ig on B cell repertoires or, alternatively, be a consequence of a better control of recurrent infections. In our study, however, no difference in the serum concentration of IgM was observed between patients substituted with i.v. Ig and untreated patients (1). In addition, PCA did not discriminate between self-reactive Ab repertoires of IgM of i.v. Ig-treated and untreated HIM patients. Since the concentration of IgG in the serum of the 12 patients treated with i.v. Ig was significantly lower than that in the serum of healthy individuals (2.6 ± 2.1 mg/ml), the possibility remains that IgG was at too low a concentration in plasma to efficiently influence the selection of B cell repertoires. Thus, it is unclear at present whether alterations in the self-reactive repertoires of IgM in patients with HIM are strictly dependent on defective T cell/B cell signaling or whether these alterations are also a consequence of decreased levels of autologous IgG.

Increased concentrations of IgM in the serum of patients with HIM were not associated with an increase in the overall reactivity of IgM with self Ags. In fact, the total autoreactivity of IgM of patients was significantly lower than that of controls in the case of three of the four tissue extracts that we tested as sources for self Ags. Our results agree with a previous report on HIM patients who were devoid of anti-Gal{alpha}1–3Gal Abs as compared with healthy individuals (50). However, in our study, the bias in IgM autoreactivity was restricted to protein Ags, suggesting that the role of T cell help in the selection of self-reactive B cell clones depends on the nature of the autoantigens. It may be speculated that autoimmune manifestations which were reported to occur in patients with HIM (2, 19) may be dependent on an impaired control of autoreactivity, secondary to defective T cell-B cell interactions. Increased titers of IgM in patients with HIM have been suggested to reflect a compensatory mechanism in individuals confronted with chronic stimulation of the immune system by infectious agents (1, 2). If that were the case, one would have expected a bias in the repertoire of reactivities of IgM toward bacterial Ags. However, we did not observe qualitative or quantitative differences in the repertoires of IgM toward Ags of P. aeruginosa and S. epidermidis. These observations suggest that IgM immune responses against foreign Ags similar to those of healthy individuals may occur in the absence of normal autologous T cells. In this respect, it is noteworthy that a proportion of B cells in patients with X-HIM may be induced to undergo somatic mutation (12).

There was almost no reactivity toward self Ags of IgG in the serum of the seven untreated patients with X-HIM whom we tested. In contrast, when tested at a similar concentration, IgG in the serum of healthy individuals reacted with several protein Ags in homologous tissue extracts. The lack of self reactivity of IgG in HIM serum may be a consequence of defective signaling through CD40 and CD40L, suggesting the requirement for normal T and B cell interactions for the generation of natural autoantibodies of the IgG isotype. An alternative hypothesis is that IgG autoantibodies are produced in HIM but that IgG autoreactivity is masked in serum by autologous IgM, as previously shown in normal serum (51, 52).

Taken together, our observations emphasize the key role of T lymphocytes in establishing natural self-reactive Ab repertoires.


    Acknowledgments
 
Bacterial extracts were kindly provided by C. Barreau (Institut Pasteur, Paris, France). We thank J. P. Fenelon for assistance in the statistical analysis.


    Footnotes
 
1 This work was supported by Institut National de la Santé et de la Recherche Médicale, France, and the Central Laboratory of the Swiss Red Cross (Bern, Switzerland). S.L.D. is a recipient of a grant from the Ministère de l’Education Nationale et de la Recherche, France. I.R. is a recipient of a grant from the European Union (PECO). Back

2 Address correspondence and reprint requests to Dr. Michel D. Kazatchkine, INSERM U430, Hôpital Broussais, 96, rue Didot, 75014 Paris, France. Back

3 Abbreviations used in this paper: HIM, hyper-IgM syndrome; X-HIM, X-linked HIM; CD40L, CD40 ligand; PCA, principal component analysis; LDA, linear discriminant analysis; LDL, low density lipoprotein. Back

Received for publication September 30, 1998. Accepted for publication February 12, 1999.


    References
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 

  1. Levy, J., T. Espanol-Boren, C. Thomas, A. Fischer, P. Tovo, P. Bordigoni, I. Resnick, A. Fasth, M. Baer, L. Gomez, E. Sanders, M. Tabone, D. Plantaz, A. Etzioni, V. Monafo, M. Abinun, L. Hammarstrom, T. Abrabamsen, A. Jones, A. Finn, T. Klemola, E. De Vries, O. Sanal, M. Peitsch, L. Notarangelo. 1997. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131:47.[Medline]
  2. Notarangelo, L. D., M. Duse, and A. G. Ugazio. 1992. Immunodeficiency with hyper-IgM (HIM). In Immunodeficiencies, F. S. R. a. M. Seligmann, ed. Harwood Academic, Chur, p. 45.
  3. Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche, D. K. Simoneaux, et al 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990.[Abstract]
  4. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. Grosmaire, R. Stenkamp, M. Neubauer, et al 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291.[Medline]
  5. DiSanto, J. P., J. Y. Bonnefoy, J. F. Gauchat, A. Fischer, G. de Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:541.[Medline]
  6. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, R. S. Rosen, T. Chatila, S. M. Fu, I. Stamenkovic, R. S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA 90:2170.[Abstract/Free Full Text]
  7. Korthauer, U., D. Graf, H. W. Mages, F. Briere, M. Padayachee, S. Malcolm, A. G. Ugazio, L. D. Notarangelo, R. J. Levinsky, R. A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539.[Medline]
  8. Notarangelo, L., M. C. Peitsch. 1996. CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol. Today 17:511.[Medline]
  9. Callard, R. E., R. J. Armitage, W. C. Fanslow, M. K. Spriggs. 1993. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14:559.[Medline]
  10. Kroczek, R. A., D. Graf, D. Brugnoni, S. Giliani, U. Korthuer, A. Ugazio, G. Senger, H. W. Mages, A. Villa, L. D. Notarangelo. 1994. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1).". Immunol. Rev. 138:39.[Medline]
  11. Villa, A., L. D. Notarangelo, J. P. Di Santo, P. P. Macchi, D. Strina, A. Frattini, F. Lucchini, C. M. Patrosso, S. Giliani, E. Mantuano, et al 1994. Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc. Natl. Acad. Sci. USA 91:2110.[Abstract/Free Full Text]
  12. Razanajaona, D., C. van Kooten, S. Lebecque, J.-M. Bridon, S. Ho, S. Smith, R. Callard, J. Banchereau, F. Briere. 1996. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome. J. Immunol. 157:1492.[Abstract]
  13. Gray, D., P. Dullforce, S. Jainandunsing. 1994. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction. J. Exp. Med. 180:141.[Abstract/Free Full Text]
  14. Kawabe, T., T. Naka, K. Yoshida, S. Suematsu, N. Yoshida, T. Kishimito, H. Kikutani. 1994. The immune response in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.[Medline]
  15. Xu, J., T. Foy, J. Laman, T. Waldschmidt, J. Elsemore, R. Noelle, R. Flawell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.[Medline]
  16. Foy, T., J. Laman, J. Ledbetter, A. Aruffo, E. Claassen, R. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157.[Abstract/Free Full Text]
  17. Lane, P.. 1997. Molecular mechanisms involved in T-B interactions. M. F. A. F. Caligaris-Cappio, ed. Human B Cell Populations 1. Karger, Basel.
  18. Facchetti, F., C. Appiani, L. Salvi, J. Levy, L. D. Notarangelo. 1995. Immunohistological analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM: abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J. Immunol. 154:6624.[Abstract]
  19. Hinz, C. F. J., and J. T. Boyer. 1963. Dysgammaglobulinemia in the adult manifested as autoimmune hemolytic anemia. N. Engl. J. Med. 269.
  20. Ackerman, B. D.. 1964. Dysagammaglobulinemia: report of a case with a family history of a congenital gammaglobulin disorder. Pediatrics 34:211.[Abstract/Free Full Text]
  21. Beall, G. N., R. F. Ashman, M. E. Miller, C. Easwaran, R. Raghunathan, J. Louie, Y. Yoshikawa. 1980. Hypogammaglobulinemia in mother and son. J. Allergy Clin. Immunol. 65:471.[Medline]
  22. Pascual-Saldeco, D., E. G. de la Concha, M. C. Garcia-Rodrigueza, J. M. Zabay, T. Sainz, G. Fontan. 1983. Cellular basis of hyper IgM immunodeficiency. J. Clin. Lab. Immunol. 10:29.[Medline]
  23. Benkerrou, M., M. L. Gougeon, C. Griscelli, A. Fischer. 1990. Hypogammaglobulinemie M: a propos de 12 observations. Arch. Fr. Pediatr. 47:345.[Medline]
  24. Avrameas, S., B. Guilbert, G. Dighiero. 1981. Natural antibodies against tubulin, actin, myoglobin, thyroglobulin, fetuin, albumin and transferrin are present in normal human sera and monoclonal immunoglobulins from multiple myeloma and Waldenström’s macroglobulinemia may express similar antibody specificities. Ann. Inst. Pasteur Immunol. 132C:231.
  25. Guilbert, B., G. Dighiero, S. Avrameas. 1982. Naturally occurring antibodies against nine common antigens in normal human sera. I. Detection, isolation, and characterization. J. Immunol. 128:2779.[Medline]
  26. Pfueller, S. L., D. Logan, T. T. Tran, R. A. Bilston. 1990. Naturally occurring human IgG antibodies to intracellular and cytoskeletal components of human platelets. Clin. Exp. Immunol. 79:367.[Medline]
  27. Mouthon, L., M. Haury, S. Lacroix-Desmazes, C. Barreau, A. Coutinho, M. D. Kazatchkine. 1995. Analysis of the normal human IgG antibody repertoire: evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues. J. Immunol. 154:5769.[Abstract]
  28. Mouthon, L., A. Nobrega, N. Nicolas, S. V. Kaveri, C. Barreau, A. Coutinho, M. D. Kazatchkine. 1995. Invariance and restriction towards a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc. Natl. Acad. Sci. USA 92:3839.[Abstract/Free Full Text]
  29. Lacroix-Desmazes, S., L. Mouthon, A. Coutinho, M. D. Kazatchkine. 1995. Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens. Eur. J. Immunol. 25:2598.[Medline]
  30. Nobrega, A., M. Haury, A. Grandien, E. Malanchère, A. Sunblad, A. Coutinho. 1993. Global analysis of antibody repertoires. II. Evidence for specificity, self-selection and the immunological "homunculus" of antibodies in normal serum. Eur. J. Immunol. 23:2851.[Medline]
  31. Sobel, E. S., V. N. Kakkanaiah, M. Kakkanaiah, R. L. Cheek, P. L. Cohen, R. A. Eisenberg. 1994. T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J. Immunol. 152:6011.[Abstract]
  32. Kuwana, M., T. A. Medsger, T. M. Wright. 1995. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis. J. Immunol. 155:2703.[Abstract]
  33. Huetz, F., E. L. Larsson-Sciard, P. Pereira, D. Portnoï, A. Coutinho. 1988. T cell dependence of the natural autoreactive B cell activation in the spleen of normal mice. Eur. J. Immunol. 18:1615.[Medline]
  34. Malanchere, E., M. A. Marcos, A. Nobrega, A. Coutinho. 1995. Studies on the T cell dependence of natural IgM and IgG adult mice. Eur. J. Immunol. 25:1358.[Medline]
  35. Mouthon, L., S. Lacroix-Desmazes, A. Nobrega, C. Barreau, A. Coutinho, M. D. Kazatchkine. 1996. The self-reactive antibody repertoire of normal human serum IgM is acquired in early childhood and remains stable throughout life. Scand. J. Immunol. 44:243.[Medline]
  36. Seyama, K., R. Kobayashi, H. Hasle, A. Apter, J. Rutledge, D. Rosen, H. Ochs. 1998. Parvovirus B19 induced anemia as presenting manifestation of X-linked hyper IgM syndrome. J. Infect. Dis. 178:318.[Medline]
  37. Haury, M., A. Grandien, A. Sundblad, A. Coutinho, A. Nobrega. 1994. Global analysis of antibody repertoires. 1. An immunoblot method for the quantitative screening of a large number of reactivities. Scand. J. Immunol. 39:79.[Medline]
  38. Jobson, J. D.. 1992. In Applied multivariate data analysis: categorical and multivariate methods Vol. 2: Springer-Verlag, New York.
  39. Coutinho, A., M. D. Kazatchkine, S. Avrameas. 1995. Natural autoantibodies. Curr. Opin. Immunol. 7:812.[Medline]
  40. Mouthon, L., S. Lacroix-Desmazes, M. D. Kazatchkine. 1998. Analysis of self-reactive antibody repertoires in normal pregnancy. J. Autoimmunity 11:279.[Medline]
  41. Ferreira, C., L. Mouthon, A. Nobrega, M. Haury, M. D. Kazatchkine, E. Ferreira, F. Padua, A. Coutinho, A. Sundblad. 1997. Instability of natural antibody repertoires in systemic lupus erythematosus patients, revealed by multiparametric analysis of serum antibody reactivities. Scand. J. Immunol. 45:331.[Medline]
  42. Sharshar, T., S. Lacroix-Desmazes, L. Mouthon, S. V. Kaveri, P. Gajdos, M. D. Kazatchkine. 1998. Selective impairment of serum antibody repertoires toward muscle and thymus antigens in patients with seronegative and seropositive myasthenia gravis. Eur. J. Immunol. 28:2344.[Medline]
  43. Malanchere, E., F. Huetz, A. Coutinho. 1997. Maternal IgG stimulates B lineage cell development in the progeny. Eur. J. Immunol. 27:788.[Medline]
  44. Kazatchkine, M. D., G. Dietrich, V. Hurez, N. Ronda, B. Bellon, F. Rossi, S. V. Kaveri. 1994. V Region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v. Ig). Immunol. Rev. 139:79.[Medline]
  45. van Doorn, P. A., F. Rossi, A. Brand, M. van Lint, M. Vermeulen, M. D. Kazatchkine. 1990. On the mechanism of high dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 29:57.[Medline]
  46. Dietrich, G., F. Varela, V. Hurez, M. Bouanani, M. D. Kazatchkine. 1993. Selection of the expressed B cell repertoire by infusion of normal immunoglobulin G in a patient with autoimmune thyroiditis. Eur. J. Immunol. 23:2945.[Medline]
  47. Espanol, T., C. Canals, A. Bofill, A. Moreno, and M. Sentis. 1986. Immunological abnormalities in late onset rubella syndrome and correction with gammaglobulin treatment. In Progress in Immunodeficiency Research and Therapy II, J. V. a. C. Griscelli, ed. Elsevier, Amsterdam, p. 401.
  48. Barth, W. F., R. Asofsky, T. J. Liddy, Y. Tanaka, D. S. Rowe, J. L. Fahey. 1965. An antibody deficiency syndrome: selective immunoglobulin deficiency with reduced synthesis of {gamma} and {alpha} immunoglobulin polypeptide chains. Am. J. Med. 39:319.
  49. Huntley, C., J. Lafferty, A. Lyerly. 1963. Antibody deficiency syndrome with increased gamma1 M (ß2M) globulins and absent {gamma}1 A (ß2A) globulins and {gamma}2 (G) globulins. Pediatrics 32:407.[Abstract/Free Full Text]
  50. Parker, W., P. B. Yu, Z. E. Holzknecht, K. Lundberg, R. H. Buckley, J. L. Platt. 1997. Specificity and function of "natural" antibodies in immunodeficient subjects: clues to B cell lineage and development. J. Clin. Immunol. 17:311.[Medline]
  51. Adib, M., J. Ragimbeau, S. Avrameas, T. Ternynck. 1990. IgG autoantibody activity in normal mouse serum is controlled by IgM. J. Immunol. 145:3807.[Abstract]
  52. Hurez, V., S. V. Kaveri, M. D. Kazatchkine. 1993. Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur. J. Immunol. 23:783.[Medline]



This article has been cited by other articles:


Home page
Mult SclerHome page
H Zephir, D Lefranc, S Dubucquoi, J de Seze, L Boron, L Prin, and P Vermersch
Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis
Multiple Sclerosis, May 1, 2009; 15(5): 593 - 600.
[Abstract] [PDF]


Home page
JEMHome page
M. Herve, I. Isnardi, Y.-s. Ng, J. B. Bussel, H. D. Ochs, C. Cunningham-Rundles, and E. Meffre
CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance
J. Exp. Med., July 9, 2007; 204(7): 1583 - 1593.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Lefranc, L. Almeras, S. Dubucquoi, J. de Seze, P. Vermersch, and L. Prin
Distortion of the Self-Reactive IgG Antibody Repertoire in Multiple Sclerosis as a New Diagnostic Tool
J. Immunol., January 1, 2004; 172(1): 669 - 678.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. D. Arkwright, M. Abinun, and A. J. Cant
Autoimmunity in human primary immunodeficiency diseases
Blood, April 15, 2002; 99(8): 2694 - 2702.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-J. Jacobin, J. Laroche-Traineau, M. Little, A. Keller, K. Peter, M. Welschof, A. Nurden, and G. Clofent-Sanchez
Human IgG Monoclonal Anti-{alpha}IIb{beta}3-Binding Fragments Derived from Immunized Donors Using Phage Display
J. Immunol., February 15, 2002; 168(4): 2035 - 2045.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Martinez-Barnetche, V. Madrid-Marina, R. A. Flavell, and J. Moreno
Does CD40 Ligation Induce B Cell Negative Selection?
J. Immunol., February 1, 2002; 168(3): 1042 - 1049.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Stahl, S. Lacroix-Desmazes, D. Heudes, L. Mouthon, S. V. Kaveri, and M. D. Kazatchkine
Altered control of self-reactive IgG by autologous IgM in patients with warm autoimmune hemolytic anemia
Blood, January 1, 2000; 95(1): 328 - 335.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lacroix-Desmazes, S.
Right arrow Articles by Kazatchkine, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lacroix-Desmazes, S.
Right arrow Articles by Kazatchkine, M. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS